1. Home
  2. TWI vs CTNM Comparison

TWI vs CTNM Comparison

Compare TWI & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Titan International Inc. (DE)

TWI

Titan International Inc. (DE)

HOLD

Current Price

$9.92

Market Cap

691.3M

Sector

Industrials

ML Signal

HOLD

Logo Contineum Therapeutics Inc.

CTNM

Contineum Therapeutics Inc.

HOLD

Current Price

$15.49

Market Cap

575.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWI
CTNM
Founded
1890
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
691.3M
575.3M
IPO Year
1997
2024

Fundamental Metrics

Financial Performance
Metric
TWI
CTNM
Price
$9.92
$15.49
Analyst Decision
Strong Buy
Buy
Analyst Count
2
5
Target Price
$11.50
$18.60
AVG Volume (30 Days)
551.9K
197.4K
Earning Date
06-01-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.93
$3.35
52 Week High
$11.70
$16.33

Technical Indicators

Market Signals
Indicator
TWI
CTNM
Relative Strength Index (RSI) 45.89 59.89
Support Level $8.24 $10.17
Resistance Level $10.03 $16.01
Average True Range (ATR) 0.50 0.90
MACD -0.16 -0.06
Stochastic Oscillator 19.47 66.40

Price Performance

Historical Comparison
TWI
CTNM

About TWI Titan International Inc. (DE)

Titan International Inc is a manufacturer of wheels, tires, wheel and tire assemblies, and undercarriage systems and components for off-highway vehicles. The company operates through three segments namely Agricultural, Earthmoving/Construction, and Consumer. Geographically, business of the group can be seen in the United States, Europe / CIS, Latin America and Other international. Titan derives majority of the revenue from Agricultural segment which manufacture various agricultural equipment, including tractors, combines, plows, planters and irrigation equipment, and are sold directly to original equipment manufacturers and to the aftermarket through independent distributors, equipment dealers and Titan's own distribution centers.

About CTNM Contineum Therapeutics Inc.

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

Share on Social Networks: